Meet Paul Mann: CEO & Chairman of ASP Isotopes

ASP Isotopes, a leading isotope enrichment company, harnesses cutting-edge technology developed over two decades in South Africa to enrich isotopes of elements and molecules with low atomic masses. Many of these elements are impractical to enrich using conventional methods like centrifuges. ASP Isotopes' primary mission is to produce and market highly enriched isotopes, catering to the healthcare and technology sectors. For more information about our groundbreaking work, please visit https://bit.ly/ASPIinfo." RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time. ASP Isotopes (ASPI) agreed to pay RedChip Companies, Inc., a $12,500 monthly cash fee and $50,000 of Rule 144 stock, deemed earned immediately after the IPO, beginning in August 2022, for 12 months of RedChip investor awareness services. ASPI also agreed to pay RedChip a fifty-thousand dollar fee for a national TV ad campaign scheduled to air weekdays in May 2024. For full disclosure, visit RedChip.com/disclosures.